2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Ex Vivo End Ischemic Hypothermic Oxygenated Perfusion (hope) Versus Static Cold Storage Prior To Liver Transplantation – Preliminary Results Of The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The Vitasmart Liver Machine Perfusion System (clinicaltrials.gov: Nct05045794)

D. J. Reich¹, A. Schlegel², M. Rizzari³, D. Foley⁴, M. DeVera⁵, W. Chapman⁶, G. Roll⁷, A. Saharia⁸, C. Quintini⁹, S. Florman¹⁰, S. Merani¹¹, S. Mao¹², A. Pinna¹³, M. Akoad¹⁴, C. Kubal¹⁵, S. Alexopoulos¹⁶, H. Bohorquez¹⁷
Ex Vivo Liver Resection and Autotransplantation – Should It Be Used More Frequently?

J. Weiner¹, A. Griesemer¹, A. Hemming², D. Levi³, T. Beduschi⁴, R. Matsumoto¹, A. Mathur¹, J. Emond¹, T. Kato¹
Ex Vivo Modification of Vascular Allografts Using Immunosuppressive and Anti-Inflammatory Polymers Prevent Rejection via Localized Immunosuppression

H. D. Luo¹, E. M. Siren¹, W. Enns², L. Sim¹, C. Du¹, S. G. Withers¹, J. Choy³, J. N. Kizhakkedathu¹
Exacerbation of Racial Disparities in Living Donor Kidney Transplant During the Covid-19 Pandemic

N. Singh¹, R. Li², T. Alhamad³, M. A. Schnitzler⁴, R. B. Mannon⁵, M. D. Doshi⁶, K. J. Woodside⁶, B. E. Hippen⁷, M. Cooper⁸, J. Snyder⁹, D. A. Axelrod¹⁰, K. L. Lentine⁴
Excellent Long-Term Outcome of ABO-Incompatible Living Kidney Transplantation by Reduced-Session of Plasmapheresis of Desensitization Protocol

Y. Ishiyama¹, K. Tanabe², T. Kanzawa², K. Unagami², H. Ishida², T. Takagi²
Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience

N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young
Exosomal TGFbeta:LAP as Immunosuppressive Mediator of Allo-Tolerance

W. Burlingham¹, E. Jankowska-Gan², J. Fechner³, C. Little², J. Sullivan⁴, D. Foley¹
Expanded Criteria Donor with Severe Acute Kidney Injury: Worth to Use?

S. Thotsiri, N. Sutharattanapong, C. Janphram, P. Wiwattanathum
Expanded Experience with Ultra-Short Duration Pangenotypic Direct Acting Anti-Viral (DAA) Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic (HCV) Donors to Hepatitis C Negative Kidney Transplant Recipients (KT)

I. Yakubu, D. Kumar, A. Sharma, M. Levy, L. Kamal, G. Gupta
Expanding Access to Robotic Kidney Transplantation for Candidates with High BMI. A Training Tool for Transplant Centers

J. A. Almario Alvarez, G. Aguiluz, V. Valle, R. Bustos, S. Akshelyan, A. M. Fratti, P. D. Cocco, M. Spaggiari, I. G. Tzvetanov, E. Benedetti

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z